Immunoregulation Of A CB2 Receptor Agonist In A Murine Model Of NeuroAIDS

HIV/AIDS

Key Findings

Previous works demonstrated that the endocannabinoid system modulates neuroimmunity and as such neuronal and glial functions. In this study results support the notion that CB2 receptor agonists may be a viable therapeutic candidate for HIV-1-associated neurocognitive disorders.

Information and Links


Link: Immunoregulation Of A CB2 Receptor Agonist In A Murine Model Of NeuroAIDS

Year: 2010

DOI: 10.1007/s11481-010-9225-8


Ratings

(How Ratings Work)

HIV/AIDS — 2


Possible to probable range of efficacy of cannabis for treatment of HIV/AIDS according to the results found in this study.

Drugs Used

A highly selective CB2R agonist, Gp1a